Facing ̽»¨Ö±²¥New Reality
05 March 2024Climate action film "Facing ̽»¨Ö±²¥New Reality" featuring Cambridge Zero Director Professor Emily Shuckburgh is a finalist for the Smiley Charity Film Awards.
Climate action film "Facing ̽»¨Ö±²¥New Reality" featuring Cambridge Zero Director Professor Emily Shuckburgh is a finalist for the Smiley Charity Film Awards.
Dawn is now being deployed for use by scientists within Cambridge and across the UK to support ambitious goals in clean energy, personalised medicine and climate.
Sir Simon Schama and Didier Queloz are among the speakers discussing the topic of revolution at the Darwin Lectures 2024.
Twelve academics from the ̽»¨Ö±²¥ of Cambridge have been ranked among the top female scientists in the world - with one claiming the top spot for Europe.
Professor Anne Ferguson-Smith, Pro-Vice-Chancellor for Research and International Partnerships at the ̽»¨Ö±²¥ of Cambridge, has been appointed Executive Chair of the Biotechnology and Biological Sciences Research Council (BBSRC).
Ìý
Youth leaders and world figures featured in new ActNowFilm, to premiere at COP28 call for young people to be included in national climate negotiation teams and global decision-making.
A floating, solar-powered device that can turn contaminated water or seawater into clean hydrogen fuel and purified water, anywhere in the world, has been developed by researchers.
̽»¨Ö±²¥Cambridge Open Zettascale Lab is hosting Dawn, the UK’s fastest artificial intelligence (AI) supercomputer, which has been built by the ̽»¨Ö±²¥ of Cambridge Research Computing Services, Intel and Dell Technologies.
Cambridge Zero Director Professor Emily Shuckburgh took centre stage at the world's biggest climate event of its kind in New York to talk to global leaders of government, business and philanthropy about Cambridge’s efforts to tackle climate change.
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. ̽»¨Ö±²¥studies suggest that a single vaccine with combinations of these antigens – a substance that causes the immune system to produce antibodies against it – could protect against an even greater range of current and future coronaviruses.